BHC
Bausch Health Companies IncNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$2.01B
P/E Ratio
12.88
EPS
$0.42
Beta
0.40
52W High
$8.69
52W Low
$4.25
50-Day MA
$5.59
200-Day MA
$6.45
Dividend Yield
—
Profit Margin
1.53%
Forward P/E
1.24
PEG Ratio
0.01
About Bausch Health Companies Inc
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.
Fundamentals
| Revenue (TTM) | $10.27B |
| Gross Profit (TTM) | $7.25B |
| EBITDA | $3.40B |
| Operating Margin | 25.80% |
| Return on Equity | 43.60% |
| Return on Assets | 5.18% |
| Revenue/Share (TTM) | $27.68 |
| Book Value | $-1.50 |
| Price-to-Book | 18.78 |
| Price-to-Sales (TTM) | 0.20 |
| EV/Revenue | 2.098 |
| EV/EBITDA | 6.78 |
| Quarterly Earnings Growth (YoY) | 1368.00% |
| Quarterly Revenue Growth (YoY) | 9.30% |
| Shares Outstanding | $370.56M |
| Float | $222.97M |
| % Insiders | 11.03% |
| % Institutions | 66.16% |
Analyst Ratings
Consensus ($7.71 target)
1
Strong Buy8
HoldData last updated: 4/7/2026